Clinical Trial Update: A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating lansoprazole in hospitalized neonates with gastroesophageal reflux disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Lansoprazole (Lansoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux Disease | Phase 1 | Status: COMPLETED